Two new patents for Endra Life Sciences
ANN ARBOR–Endra Life Sciences Inc. (NASDAQ: NDRA), the Ann Arbor-based ultrasound technology developer, has won two new patents from the United States Patent and Trademark Office. They are U.S. Patent …
HistoSonics treats first patients in European clinical trial
ANN ARBOR—Officials at HistoSonics, developer of novel ultrasound therapies, announced today that the first patient has been treated as part of the company’s #HOPE4LIVER Europe Trial, which was approved by …
First patient treated with HistoSonics sonic beams for liver tumors
ANN ARBOR—HistoSonics, developer of a non-invasive sonic beam therapy, announced today the treatment of the first patient in the #HOPE4LIVER US Study. The investigational device study was approved by the …
New study shows advantage for Novi startup’s breast exam technology
NOVI—The ultrasound breast examination technology being developed by a Novi medical device startup, Delphinus Medical Technologies Inc., has been shown to be predictive of future breast cancers, according to a …
Delphinus Moves To New, Larger HQ
PLYMOUTH TWP. — Delphinus Medical Technologies Inc., developers of a novel ultrasound technology for detecting breast tumors, is moving this week to a new, larger headquarters in Novi, according to …